Increasing Adoption of a Telehealth-Delivered Collaborative Care Program for Patients With Lung Cancer: A Pilot Study

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this trial is to compare the impact of two outreach strategies (high touch vs. standard outreach) on a collaborative care program delivered via telehealth to patients with lung cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Are aged 18 years or older.

• Are currently being seen by Penn Medicine Thoracic Oncology for lung cancer treatment or survivorship care.

• Are referred to collaborative care by a Penn Medicine Thoracic Oncology clinician for treatment of depression, anxiety, or other psycho-therapy services.

Locations
United States
Pennsylvania
Abramson Cancer Center at the University of Pennsylvania
RECRUITING
Philadelphia
Contact Information
Primary
Jennifer Steltz, MRA
jennifer.steltz@pennmedicine.upenn.edu
215-573-2593
Backup
Jocelyn Wainwright, MS
jocelyn.wainwright@pennmedicine.upenn.edu
215-615-4226
Time Frame
Start Date: 2025-08-18
Estimated Completion Date: 2027-02
Participants
Target number of participants: 30
Treatments
Experimental: High Touch Outreach
Patients in the high touch outreach arm will receive a gain-framed message via text (preferred modality), MyPennMedicine message, email, and/or postal mail that links to the digital screener; an informational flyer about collaborative care sent via postal mail, the MyPennMedicine portal, email, and/or text; and a direct request from their oncology provider to collaborative care for those patients who have not responded to outreach efforts by their next oncology visit post-referral.
No_intervention: Standard Outreach
Patients in the standard outreach arm will receive a standard message sent via text (preferred modality), MyPennMedicine message, email, and/or postal mail that links to the digital screener; this message is one that is similar to that already used in Penn Integrated Care's practice.
Related Therapeutic Areas
Sponsors
Leads: Abramson Cancer Center at Penn Medicine
Collaborators: National Institutes of Health (NIH), National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov